Guest View
User: Pass: | become a member


Dimon’s JPMorgan Stock Purchase Aims To Put Investors At Ease

Courtesy of Benzinga.

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that on July 16, 2012, the compensation committee of BioMarin’s board of directors approved the grant to two employees of stock options to purchase 13,400 shares of common stock in the aggregate and the grant of 1,310 restricted stock units to one of the employees.

The stock options and restricted stock units were granted pursuant to the BioMarin Pharmaceutical Inc. 2012 Inducement Plan, approved by the compensation committee of BioMarin’s board of directors on May 8, 2012 and as inducements material to the new employees entering into employment with BioMarin in accordance with NASDAQ Listing Rule 5635(c)(4).


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!




You must be logged in to make a comment.
You can sign up for a membership or get a free SWW trial or log in.

Dashboard

 Sector Performances (Today)

 Thermal Imaging

Medical0.63 %
 
Aerospace0.46 %
 
Construction0.42 %
 
Retail-Wholesale0.41 %
 
Computer and Technology0.30 %
 
Industrial Products0.20 %
 
Consumer Staples0.17 %
 
Consumer Discretionary0.13 %
 
Oils-Energy0.09 %
 
Basic Materials-0.06 %
 
Multi-Sector Conglomerate-0.11 %
 
Transportation-0.20 %
 
Business Services-0.21 %
 
Utilities-0.28 %
 
Finance-0.29 %
 
Auto-Tires-Trucks-0.48 %